2012 |
|
|
01.02.12 |
Release of escrow securities |
|
30.01.12 |
Appendix 4C - Quarterly |
|
19.01.12 |
Revised Share Trading Policy |
|
18.01.12 |
Shareholder Update |
|
16.01.12 |
Appointment of Alternate Director and
Appendix 3X |
|
|
|
|
2011 |
|
|
30.12.11 |
Repayment of Convertible Notes |
|
28.12.11 |
Appendix 3Z - Final Director`s Interest
Notices X 2 |
|
27.12.11 |
Resignations from the Board of Directors |
|
21.12.11 |
Change of Director`s Interest Notice |
|
21.12.11 |
Amended Change of Director`s Interest
Notice |
|
21.12.11 |
Clarification to response to ASX query |
|
20.12.11 |
Response to ASX query |
|
19.12.11 |
Change of Director`s Interest Notice |
|
16.12.11 |
Update: Novo Nordisk Option Agreement |
|
12.12.11 |
Chairman's letter to Shareholders and
Shareholder update |
|
01.12.11 |
Appointment of Chairman, Appointment of
Interim MD, Reduction in Directors' Fees |
|
30.11.11 |
Results of Meeting |
|
29.11.11 |
AGM Chairman`s address |
|
29.11.11 |
Resignations from the Board of Directors
|
|
25.11.11 |
Final Director`s Interest Notices x 2
|
|
25.11.11 |
Change of Director`s Interest Notices
x 3 |
|
22.11.11 |
Clinical trial data presented at ACR Scientific
Meeting |
|
21.11.11 |
Resignations from the Board of Directors |
|
21.11.11 |
Correction to investment presentation
|
|
11.11.11 |
Replacement 2011 AGM documents |
|
10.11.11 |
Initial Director's Interest Notice x 5 |
|
10.11.11 |
Ceasing to be a substantial holder |
|
07.11.11 |
CBio addresses shareholder feedback |
|
04.11.11 |
Appointment of New Non-Executive Directors
|
|
04.11.11 |
Cleansing statement |
|
04.11.11 |
Results of Meeting |
|
04.11.11 |
Appendix 3B |
|
04.11.11 |
Final Director`s Interest Notices x 3
|
|
01.11.11 |
Resignations from Board of Directors |
|
01.11.11 |
Placement |
|
31.10.11 |
Appendix 4C |
|
28.10.11 |
Lupus data published in Oxford Journals
|
|
28.10.11 |
Trading Halt |
|
27.10.11 |
Resignation and Appointment: Company Secretary |
|
26.10.11 |
Phase IIa RA data to be presented at American
College Rheumatology |
|
26.10.11 |
Final Directors Interest Notice |
|
26.10.11 |
Board and Management Change |
|
26.10.11 |
Section 708A Notice |
|
26.10.11 |
Appendix 3B |
|
26.10.11 |
Shortfall Allotment |
|
20.10.11 |
Change of Directors Notice x 2 |
|
20.10.11 |
Letter to Shareholders |
|
20.10.11 |
AGM Notice of Meeting |
|
12.10.11 |
Receipt of Final Clinical Study Report |
|
12.10.11 |
Rights Issue Share Allotment |
|
12.10.11 |
Shortfall Announcement |
|
12.10.11 |
Announcement: Changes to Board and Executive
|
|
26.09.11 |
Notice of Meeting and Proxy Form |
|
21.09.11 |
Annual Report to Shareholders |
|
19.09.11 |
Updated Investor Presentation |
|
12.09.11 |
s249D Notice - update |
|
05.09.11 |
Receipt of Notice under s249D |
|
05.09.11 |
Investor Presentation |
|
05.09.11 |
Appendix 3B |
|
05.09.11 |
Letter to Convertible Note Holders |
|
05.09.11 |
Letter to optionholders |
|
05.09.11 |
Letter to ineligible shareholders |
|
05.09.11 |
Letter to eligible shareholders |
|
05.09.11 |
Non-Renounceable Rights Issue Prospectus |
|
05.09.11 |
Announcement of Underwritten Rights Issue
|
|
02.09.11 |
Becoming a substantial holder |
|
01.09.11 |
Trading Halt |
|
31.08.11 |
Preliminary Final Report |
|
25.08.11 |
Termination of Convertible Loan Facility |
|
03.08.11 |
Repayment of Convertible Note |
|
31.07.11 |
Headline clinical trial results |
|
25.07.11 |
Appendix 4C - Quarterly |
|
25.07.11 |
Request for voluntary suspension from
trading |
|
19.07.11 |
Appendix 3B |
|
19.07.11 |
Appendix 3Y |
|
19.07.11 |
Section 708A |
|
15.07.11 |
Results of Meeting |
|
13.07.11 |
Withdrawal of Resolutions |
|
12.07.11 |
Clinical Trial Update |
|
07.07.11 |
Appendix 3B |
|
07.07.11 |
Section 708A Notice |
|
06.07.11 |
Appendix 3B |
|
01.07.11 |
Notice of Conversion of Notes |
|
30.06.11 |
Repayment of Convertible Notes |
|
28.06.11 |
Letter to Shareholders from the Executive
Chairman |
|
28.06.11 |
Change of Director's Interest Notice |
|
10.06.11 |
Notice of General Meeting/Proxy Form |
|
03.06.11 |
Change of Director`s Interest Notice x
2 (Appendix 3Y) |
|
03.06.11 |
Appendix 3B |
|
30.05.11 |
Repayment of Convertible Note |
|
26.05.11 |
Section 708A Notice |
|
26.05.11 |
Appendix 3B |
|
26.05.11 |
Final Placement Share Issue |
|
23.05.11 |
Section 708A Notice |
|
23.05.11 |
Appendix 3B |
|
23.05.11 |
Allotment of placement shares |
|
20.05.11 |
Section 708A Notice |
|
20.05.11 |
Appendix 3B |
|
12.05.11 |
CBio Completes $5.1 Million Share Placement
|
|
10.05.11 |
Response to Appendix 4C query |
|
10.05.11 |
Trading halt |
|
03.05.11 |
Appendix 3B |
|
29.04.11 |
Appendix 4C - Quarterly |
|
29.04.11 |
Section 708A Notice |
|
29.04.11 |
Appendix 3B |
|
27.04.11 |
Convertible Note Repayment |
|
20.04.11 |
Resignation of non-executive director |
|
20.04.11 |
Appendix 3Z |
|
31.03.11 |
Appendix 3B |
|
28.03.11 |
Appendix 3B - correction |
|
28.03.11 |
Appendix 3B |
|
28.03.11 |
Section 708(A) Notice |
|
28.03.11 |
Dosing complete in phase IIa rheumatoid
arthritis clinical trial |
|
25.03.11 |
Repayment of convertible note |
|
23.03.11 |
Section 708(A) Notice |
|
23.03.11 |
Appendix 3B |
|
23.03.11 |
Change of Director`s Interest Notice |
|
09.03.11 |
Change in substantial holding |
|
09.03.11 |
Change of Director`s Interest Notice x
3 |
|
08.03.11 |
Change in substantial holding |
|
04.03.11 |
Japanese Patent Granted |
|
01.03.11 |
Appendix 3B |
|
28.02.11 |
Change in substantial holding |
|
28.02.11 |
Change of Director`s Interest Notice |
|
22.02.11 |
Response to ASX Price Query |
|
18.02.11 |
Repayment of Convertible Note |
|
17.02.11 |
Change of Director`s Interest Notice |
|
08.02.11 |
Investment Presentation - Feburary 2011
|
|
01.02.11 |
Appendix 3B Correction |
|
31.01.11 |
Appendix 4C - quarterly |
|
31.01.11 |
Initial Director`s Interest Notice |
|
31.01.11 |
Appointment of Mr James Greig as a Director |
|
31.01.11 |
Change in substantial holding |
|
31.01.11 |
Change of Director`s Interest Notice |
|
27.01.11 |
Initial Director`s Interest Notice |
|
27.01.11 |
Appointment of Dr Thomas Lonngren To The
CBio Board |
|
27.01.11 |
Section 708(a) Notice |
|
27.01.11 |
Appendix 3B |
|
24.01.11 |
Appendix 3B |
|
19.01.11 |
Section 708A Notice |
|
19.01.11 |
Ceasing to be a substantial holder |
|
18.01.11 |
Appendix 3B |
|
18.01.11 |
Becoming a substantial holder |
|
04.01.11 |
Repayment of Convertible Note |
|
|
|
|
2010 |
|
|
24.12.10 |
Share Trading Policy |
|
24.12.10 |
Appendix 3B |
|
22.12.10 |
Appendix 3B |
|
14.12.10 |
Appendix 3B |
|
14.12.10 |
CBio completes $9.3 million capital raising
round |
|
07.12.10 |
Change in substantial holding |
|
07.12.10 |
Change of Director`s Interest Notice x
2 |
|
01.12.10 |
Appointment to the Board - Dr Terje Kalland
|
|
01.12.10 |
Appendix 3X - Initial Director`s Interest
Notice |
|
01.12.10 |
Appendix 3Y - correction |
|
| 01.12.10 |
Appendix 3Y |
|
30.11.10 |
Notice Under Section 708 |
|
30.11.10 |
Appendix 3B |
|
26.11.10 |
AGM - Results of Meeting |
|
26.11.10 |
AGM - Chairman`s Address to Shareholders |
|
26.11.10 |
AGM - CEO's Address to Shareholders |
|
26.11.10 |
AGM - CEO's Presentation |
|
24.11.10 |
Resignation of non-executive Director
Dr Dennis Feeney |
|
24.11.10 |
Appendix 3Z - Final Director`s Interest
Notice |
|
23.11.10 |
Change in substantial holding |
|
22.11.10 |
Issue of securities |
|
22.11.10 |
Appendix 3Y |
|
16.11.10 |
Repayment of Convertible Note |
|
November |
Change of Substantial Shareholder |
|
November |
Change of Substantial Shareholder - Form
604 |
|
November |
Appendix 3Y |
|
November |
Rights Issue Allotment |
|
November |
Announcement - Rights Issue Shortfall
|
|
October |
Appendix 4C |
|
October |
Announcement - Release of Escrow |
|
October |
Appendix 3B |
|
October |
Notice of Annual General Meeting |
|
October |
ASX Announcement - Annual General Meeting
|
|
October |
Announcement - Appendix 3B |
|
October |
Announcement - Repayment of Convertible
Note |
|
October |
Announcement - Release of Escrow |
|
October |
Appendix 3B |
|
September |
Announcement - Completion of Lupus study |
|
September |
Investor Presentation |
|
September |
ASX Announcement - Rights Issue |
|
September |
Notice under Section 708A - Rights Issue
|
|
September |
Rights Issue Information Booklet |
|
September |
Letter to Shareholders |
|
September |
Letter to Optionholders |
|
September |
Letter to Convertible Noteholders |
|
September |
Letter to Ineligible Shareholders |
|
September |
Appendix 3B |
|
September |
Announcement - Trading Halt |
|
September |
Appendix 3B |
|
September |
Announement - Repayment to SpringTree;
Resignation of Director |
|
September |
Announcement - Full recruitment
into RA clinical trial |
|
August |
Appendix 3B |
|
August |
Announcement - patent portfolio
development and clinical trial update |
|
August |
Appendix 3B |
|
August |
Appendix 4C clarification |
|
August |
Appendix 3B |
|
August |
Notice under S708a 5(e) |
|
July |
Appendix 4C |
|
July |
Appendix 3B |
|
July |
Notice under S708A(5)(e) of the Corporations
Act |
|
July |
Appendix 3B |
|
June |
Clinical trial recruitment milestone |
|
June |
Statement |
|
June |
Appendix 3B |
|
June |
SPP Update |
|
June |
Appendix 3B |
|
June |
Results of General Meeting |
|
June |
Chairman's Address to General Meeting
|
|
June |
Appendix 3B |
|
June |
Notice under Section 708A of the Corporations
Act |
|
June |
Appendix
3B |
|
May |
Share
Purchase Plan - Announcement |
|
May |
Share
Purchase Plan - Rules |
|
May |
Share
Purchase Plan - Cleansing Notice |
|
May |
Share
Purchase Plan - Letter to Eligible Shareholders |
|
May |
Share
Purchase Plan - Letter to Ineligible Shareholders |
|
May |
Share
Purchase Plan - Letter to Optionholders |
|
May |
Announcement
- Spring Tree Funding Facility |
|
May |
Notice
708A |
|
May |
Appendix
3B |
|
May |
Notice
of Meeting |
|
May |
Investor
Update |
|
April |
Quarterly
Update to Investors - Q2 2010 |
|
April |
Appendix
4C - Quarterly |
|
April |
Appendix
3B - Amended |
|
April |
Correction
to incorrect information in the market |
|
April |
Appendix
3B |
|
April |
Change
in Convertible Note terms |
|
March |
Change
in Substantial Shareholder |
|
March |
Appendix
3Y |
|
March |
Appendix
3B |
|
March |
Announcement
- Milestone Achievement under Option Agreement with NN |
|
March |
Announcement
- Milestone Achievement |
|
February
|
Notice of
Initial Substantial Shareholder |
|
February
|
Notice of
Initial Substantial Shareholder |
|
February
|
Correction
to Top 20 Shareholders |
|
February
|
Appendix
3X - Initial Director's Interest Notice |
|
February
|
ASX Announcement
- Commencement of official quotation |
|
February
|
Announcement
- CBio lists on ASX |
|
February
|
ASX Announcement
- Admission to the offical list |
|
February
|
Statement
on number and period of restricted securities |
|
February
|
Listing
Application and Agreement |
|
February
|
Announcement
- CBio successfully closes IPO |
|
January
|
Announcement |
|
|
|
|
2009 |
|
|
December |
Further
Supplementary Prospectus |
|
December |
Release |
|
November |
Supplementary
to IPO Prospectus |
|
November |
Annual General
Meeting - Managing Director's Address |
|
November |
Annual General
Meeting - Results of Meeting |
|
November |
CBio Limited
IPO Prospectus |
|
October |
Notice of
Meeting and Explanatory Memorandum |
|
October |
Media Release
|
|
October |
CBio Constitution
|
|
October |
Results
of EGM |
|
October |
Chairman's
Address to EGM |
|
September |
Notice of
Meeting |
|
August |
|
|
July |
Information
Release |
|
June |
Information
Release |
|
April |
Information
Release |
|
January
|
Information
Release |
|
|
|
|
2008 |
|
|
December
|
Second Supplementary
Prospectus |
|
November |
Annual General
Meeting of Shareholders - Chairman's Address |
|
November |
Annual General
Meeting of Shareholders - Managing Director's Address |
|
November |
Annual General
Meeting of Shareholders - Results of Meeting |
|
November |
Supplementary
Prospectus |
|
November |
Notice of
Meeting - AGM |
|
October |
CBio
Limited Rights Issue Prospectus |
|
June |
Announcement:
Commencement of dosing in Phase IIa RA clinical trial |
|
June |
Shareholder Newsletter |
|
May |
Information
Release - CBio commences Phase IIa RA clinical trial |
PDF |
May |
Disclosure
Announcement - CBio signs agreement with Novo Nordisk |
PDF |
May |
Information
Release - Cpn10: Evidence of Utility Beyond a Single Indication
|
|
April |
Disclosure
Announcement - Receipt of Transaction Proposal |
|
| |
|
|
2007 |
|
|
November |
AGM
- Chairman's Address to Shareholders |
|
November |
AGM
- Managing Director's Address to Shareholders |
|
November |
Notice
- Cancellation of EGM |
|
October |
Announcement
- Apointment to the Board of Directors , Dr Peter Corr |
|
October |
Notice
of Meeting - AGM |
|
October |
Disclosure
Announcement - Ceasing to be a substantial shareholder,
VLA |
|
October |
Shareholder
Announcement - Notice of EGM |
|
October |
Announcement
- Appointments to the Board of Directors |
|
July |
Substantial Holder Notice
|
|
July |
Substantial Holder Notice
|
|
May |
Second Further Suplementary
Prospectus |
|
April |
Further Supplementary
Prospectus |
|
April |
Supplementary Prospectus
|
|
March |
Prospectus |
|
|
|
|
|
|
|
2006 |
|
|
December |
Letter to Shareholders |
|
November |
Chairman's address at
AGM |
|
November |
CEO's address at AGM
|
|
November |
Letter to Shareholders |
|
August |
|
|
August |
BioCentury
News Artlcle on CBio |
|
August |
Information Release
- Rheumatoid Arthritis |
|
August |
Summary of Media Articles
|
|
August |
Disclosure Announcement
- Investment Update |
|
August |
Disclosure Announcement
- Sale of Bresagen Shares |
|
June |
Information Release
- Completion of Phase 2a clinical trial in Multiple Sclerosis |
|
June |
Information Release
- Completion of Phase 2a clinical trial in Psoriasis |
|
May |
Information Release
- Completion of Phase 2a clinical trial in Rheumatoid Arthritis |
|
April |
Letter to Shareholders |
|
|
|
|
|
|
|
2005 |
|
|
December |
Letter to Shareholders
|
|
November |
Chairman's address at
AGM |
|
June |
Information Release
- Federal Government Grant |
|
June |
Letter to Shareholders
|
|
May |
Information Release
- Termination of Phase 11(a) Clinical Trial in Ulcerative
Colitis |
|
April |
Federal Govt awards CBio $6m |
|
April |
News
Article - Australian Financial Review |
|
March |
CBio signs agreement with Griffith University for Phase
IIa trial in MS |
|
February |
The
Journal of Biological Chemistry Article |
|
January |
Prospectus |
|
|
|
|
|
|
|
2004 |
|
|
October |
Letter to Shareholders |
|
| June |
Information Memorandum |
PDF |
| |
|
|
| 2003 |
|
|
| November |
Replacement Prospectus |
PDF |
| November |
Prospectus |
PDF |
| |
|
|
| 2001 |
|
|
| June |
Prospectus |
PDF |
| |
|
|
